Compound index — D
597 substances begin with D. 2 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Desirudin – Dioscorea oppositifolia.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Desirudin Recombinant US-DRUG Not yet graded
Earliest US approval2003
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004975
Deslanoside US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004976
Desloratadine EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; R01BA52
Earliest US approval2001
Market presence25 US product listings · 22 FDA applications · 11 EU medicines
Etalyn identifierETA-C-004977
Desmodesmus communis EU-NOVEL Not yet graded
Novel, not yet authorised
also: Scenedesmus communis E.Hegewald 1977, Scenedesmus quadricauda Chodat 1926.
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-004979
Desmodesmus subspicatus EU-NOVEL Not yet graded
Novel, not yet authorised
also: Scenedesmus subspicatus Chodat 1926
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-004980
Desmodium adscendens CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004981
Desmodium styracifolium CA-NHP Not yet graded
CA licensed ingredient
Market presence25 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-004983
Desmopressin US-DRUG Not yet graded
US: anda
Class as recordedFactor VIII Activator [EPC]; Increased Coagulation Factor VIII Activity [PE]; Increased Coagulation Factor VIII Concentration [PE]; Vasopressin Analog [EPC]
Earliest US approval1978
Market presence90 US product listings · 38 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004984
Desogestrel US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1992
Market presence6 US product listings · 28 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004985
Desomorphine US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-004986
Desonide US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1972
Market presence39 US product listings · 26 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004987
Desoximetasone US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1977
Market presence43 US product listings · 40 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004988
Desoxycorticosterone Acetate US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1939
Market presence3 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004989
desoxycortone pivalate EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-004990
Desoxymethyltestosterone US-CSA Not yet graded
CSA Schedule III
Class as recordedDEA: anabolic steroid
DEA other namesMadol
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-004991
Desoxyribonuclease US-DRUG Not yet graded
Earliest US approval1964
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004992
Desugared fermented orange juice EU-NOVEL Not yet graded
Not novel in food
Parts in scopeDesugared fermented orange juice
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-004993
Desvenlafaxine EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: anda
Class as recordedCytochrome P450 2D6 Inhibitors [MoA]; Norepinephrine Uptake Inhibitors [MoA]; Serotonin Uptake Inhibitors [MoA]; Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
Earliest US approval2008
Market presence87 US product listings · 17 FDA applications · 1 EU medicines
Etalyn identifierETA-C-004994
Detomidine Hydrochloride US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004995
Deucravacitinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL04AF07; Tyrosine Kinase 2 Inhibitor [EPC]; Tyrosine Kinase 2 Inhibitors [MoA]
Earliest US approval2022
Market presence8 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-004996
Deuruxolitinib Phosphate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBile Salt Export Pump Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]; Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
Earliest US approval2024
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004997
Deutetrabenazine, (r,s)-REL- US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-004999
Deutivacaftor EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Chloride Channel Activation Potentiators [MoA]; Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]; Cytochrome P450 2C9 Inhibitors [MoA]
Earliest US approval2024
Market presence6 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005000
Devil's claw CA-NHP Not yet graded
CA licensed ingredient
Market presence50 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005001
Dexamethasone EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedAminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1958
Market presence349 US product listings · 154 FDA applications · 2 EU medicines
Etalyn identifierETA-C-005002
Dexamethasone Acetate, Unspecified Form US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005003
Dexamethasone Isonicotinate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005004
Dexbrompheniramine Maleate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic alpha1-Agonists [MoA]; Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
Earliest US approval1963
Market presence24 US product listings · 8 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005005
Dexchlorpheniramine Maleate US-DRUG Not yet graded
US: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic alpha1-Agonists [MoA]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]
Earliest US approval1981
Market presence11 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005006
Dexfosfoserine US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005007
Dexibuprofen US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005008
Dexketoprofen Tromethamine US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005009
Dexlansoprazole US-DRUG Not yet graded
US: anda
also: Dexlansoprazole Sesquihydrate
Class as recordedProton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
Earliest US approval2009
Market presence40 US product listings · 6 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005010
Dexmedetomidine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAdrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]; General Anesthesia [PE]; N05CM18
Earliest US approval1999
Market presence99 US product listings · 35 FDA applications · 5 EU medicines
Etalyn identifierETA-C-005011
Dexmethylphenidate US-DRUG Not yet graded
US: anda
Class as recordedCentral Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
Earliest US approval2001
Market presence151 US product listings · 24 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005012
Dexpanthenol US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Increased Prothrombin Activity [PE]; Photoabsorption [MoA]
Earliest US approval1947
Market presence8 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005013
Dexrazoxane EU-MEDUS-DRUG Not yet graded
Dextran 1 US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005015
Dextran 40 US-DRUG Not yet graded
US: anda
Class as recordedIncreased Intravascular Volume [PE]; Osmotic Activity [MoA]; Plasma Volume Expander [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005016
Dextran 500 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005017
Dextran 60 US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005018
Dextran 70 US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005019
Dextrin CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005020
Dextroamphetamine US-DRUG Not yet graded
US: anda
Class as recordedCentral Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
Earliest US approval1960
Market presence333 US product listings · 88 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005021
Dextroamphetamine Adipate US-DRUG Not yet graded
Earliest US approval1975
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005022
Dextroamphetamine Resin Complex US-DRUG Not yet graded
Earliest US approval1955
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005023
Dextroamphetamine Saccharate US-DRUG Not yet graded
US: anda
Class as recordedCentral Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
Earliest US approval1960
Market presence261 US product listings · 45 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005024
Dextromethorphan EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic alpha1-Agonists [MoA]; Allergens [CS]; Aminoketone [EPC]
Earliest US approval1957
Market presence2,179 US product listings · 38 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005025
Dextromethorphan Hydriodide US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005026
Dextromethorphan Polistirex US-DRUG Not yet graded
Earliest US approval1982
Market presence4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005027
Dextromoramide US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesPalfium; Jetrium; Narcolo
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005028
Dextropropoxyphene dosage forms US-CSA Not yet graded
CSA Schedule IVnarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesDarvon; propoxyphene; Darvocet; Propacet
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005030
Dextropropoxyphene, bulk US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesPropoxyphene
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005029
Dextrose CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: anda
also: Anhydrous Dextrose
Class as recordedAcidifying Activity [MoA]; Alkalinizing Activity [MoA]; Allergens [CS]; Amide Local Anesthetic [EPC]
Earliest US approval1946
Market presence276 US product listings · 153 FDA applications · 5 Canadian licensed products
Etalyn identifierETA-C-005031
Dextrose, Unspecified Form US-DRUG Not yet graded
US: nda
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
Market presence40 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005032
Dextrothyroxine Sodium US-DRUG Not yet graded
Earliest US approval1967
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005033
Dezocine US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005034
DHA ETALYNEU-CLAIM B/contestedband 4
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “DHA contributes to improved memory function” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005035
DHA and EPA ethyl esters oil from Schizochytrium sp. EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005036
Diacerein US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005037
Diacylglycerol (DAG) oil EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Substituting your usual vegetable oil with DAG oil helps in the management of body weight through weight loss” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005038
Diamine oxidase CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005039
Diaminopyrimidine Oxide US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005040
Diamond US-DRUG Not yet graded
US: unapproved homeopathic
Market presence17 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005041
Diampromide US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005042
Dianthus Caryophyllus Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005043
Dianthus superbus CA-NHP Not yet graded
CA licensed ingredient
Market presence63 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005044
Dianthus Superbus Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005045
Diastase CA-NHP Not yet graded
CA licensed ingredient
Market presence32 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005046
Diatomaceous earth (uncalcined) CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005047
Diatrizoate Sodium US-DRUG Not yet graded
US: anda
Class as recordedRadiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]
Earliest US approval1954
Market presence18 US product listings · 26 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005048
Diatrizoic Acid US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005049
Diazepam US-CSAUS-DRUG Not yet graded
Diazolidinyl Urea US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005051
Diazoxide US-DRUG Not yet graded
US: anda
Earliest US approval1973
Market presence15 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005052
Dibasic sodium phosphate CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: anda
also: Anhydrous Dibasic Calcium Phosphate
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence204 US product listings · 11 Canadian licensed products
Etalyn identifierETA-C-005054
dibotermin alfa EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedM05BC01; QM05BC01
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005055
Dibucaine US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Standardized Chemical Allergen [EPC]
Market presence8 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005056
Dicaffeine malate CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005057
Dicalcium Phosphate CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005058
Dicaprylyl Ether US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]; Glycerol [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005059
Dicentra Canadensis Root US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005060
Dicentra Formosa Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005061
Dichloralphenazone US-CSA Not yet graded
CSA Schedule IV
Class as recordedDEA: depressant
DEA other namesMidrin; dichloralantipyrine
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005062
Dichlorphenamide US-DRUG Not yet graded
US: anda
Class as recordedCarbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]
Earliest US approval1958
Market presence7 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005063
Dichlorvos US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005064
Dichroa febrifuga CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005065
Dichromate ION US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005066
Dichrostachys cinerea CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005067
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one) US-CSA Not yet graded
CSA Schedule I
also: Diclazepam -1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one)
Class as recordedDEA: depressant
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005068
Diclazuril US-DRUG Not yet graded
US: bulk ingredient
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005069
Diclofenac US-DRUG Not yet graded
US: anda
Class as recordedAmide Local Anesthetic [EPC]; Amides [CS]; Anti-Inflammatory Agents; Antiarrhythmic [EPC]
Earliest US approval1988
Market presence502 US product listings · 101 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005070
Diclofenac Diethylamine US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005071
Diclofenac Epolamine US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Decreased Prostaglandin Production [PE]; Non-Steroidal [CS]
Earliest US approval2007
Market presence18 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005072
diclofenamide EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedS01EC02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005073
Dicloxacillin Sodium US-DRUG Not yet graded
US: anda
Class as recordedPenicillin-class Antibacterial [EPC]; Penicillins [CS]
Earliest US approval1968
Market presence12 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005074
Dicoria Canescens Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005075
Dicreatine malate CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005076
Dictamnus dasycarpus CA-NHP Not yet graded
CA licensed ingredient
Market presence88 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005077
Dicumarol US-DRUG Not yet graded
Earliest US approval1944
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005078
Dicyclomine Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAnticholinergic [EPC]; Cholinergic Antagonists [MoA]
Earliest US approval1950
Market presence130 US product listings · 46 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005079
Didanosine US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1991
Market presence2 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005080
Didecyldimonium Chloride US-DRUG Not yet graded
US: otc monograph drug
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005081
Didymocarpus pedicellata CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005082
Dieffenbachia Seguine US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Androgen Receptor Agonists [MoA]; Androgen [EPC]
Market presence39 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005083
Dieffenbachia Seguine Whole US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence17 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005084
Dienestrol US-DRUG Not yet graded
Earliest US approval1947
Market presence4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005085
Dienogest US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2010
Market presence3 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005086
Dientamoeba Fragilis US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005087
Diet rich in whole grain EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “diets rich in whole grain foods promote heart health” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005088
Dietary fibre EU-CLAIM Not yet graded
EU claims 0 authorised / 9 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Dietary fibre helps to maintain a healthy immune system.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Dietary fibre helps to maintain normal blood lipid levels and a healthy cardiovascular system” | Non-authorised | Art.13(1) | EFSA opinion |
| “Dietary fibre helps to maintain normal blood sugar levels.” | Non-authorised | Art.13(1) | EFSA opinion |
| “dietary fibre as part of diet low in sugars; -dietary fibre induces a low glycemic response; -dietary fibre helps to control/ balance blood insulin/glucose level. -helps to control/ balance blood insulin/ glucose level -can help to reduce the glycemic index of a meal -has beneficial effects on blood glucose and blood insulin level -is suitable for diabetics” | Non-authorised | Art.13(1) | EFSA opinion |
| “dietary fibre: - has beneficial effects on the cholesterol level (in the blood) - helps to maintain healthy cholesterol levels” | Non-authorised | Art.13(1) | EFSA opinion |
| “.Fibre helps to reduce fat absorption.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Foods high in fibre help you to feel full for longer to help maintain your body weight.” | Non-authorised | Art.13(1) | EFSA opinion |
| “– dietary fibre helps to balance blood glucose level; – dietary fibre helps to regulate glucose level; – dietary fibre contributes to healthy glucose level; – dietary fibre helps to maintain healthy glucose level.” | Non-authorised | Art.13(1) | EFSA opinion |
| “– dietary fibre helps to maintain normal bowel/colonic function; – dietary fibre promotes bowel regularity; – ensures a healthy digestive system/function.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005090
Dietary food for special medical purposes - oral rehydrating solution with decreased osmolarity composed according to WHO/UNICEF recommendations - ORSALIT. ORSALIT is available in following versions: - ORSALIT without flavor, - ORSALIT with banana flavor EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “ORSALIT is used in all cases when dehydration may occur 2. ORSALIT is hypoosmolar, oral rehydrating solution composed according to WHO and UNICEF recommendations 3. ORSALIT helps to avoid dehydration which may occur in case of diarrhea and/or vomiting 4. ORSALIT uses mechanism of collective adsorption of water, sodium and glucose which is not damaged even during diarrhea 5. ORSALIT is used in order to supplement…” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005091
Dietary nitrate ETALYN A/contestedband 4
also: No₃⁻; beetroot juice
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-005089
Diethylamino Hydroxybenzoyl Hexyl Benzoate US-DRUG Not yet graded
US: otc monograph drug
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005092
Diethylcarbamazine Citrate US-DRUG Not yet graded
Earliest US approval1950
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005093
Diethylene Glycol Monoethyl Ether US-DRUG Not yet graded
US: otc monograph final
Class as recordedAcidifying Activity [MoA]; Ammonium Ion Binding Activity [MoA]; Nitrogen Binding Agent [EPC]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005094
Diethylpropion US-CSAUS-DRUG Not yet graded
CSA Schedule IVUS: anda
Class as recordedAppetite Suppression [PE]; DEA: stimulant; Increased Sympathetic Activity [PE]; Sympathomimetic Amine Anorectic [EPC]
Earliest US approval1959
Market presence26 US product listings · 16 FDA applications
DEA other namesTenuate; Tepanil
Etalyn identifierETA-C-005095
Diethylstilbestrol US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Earliest US approval1973
Market presence3 US product listings · 11 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005096
Diethylthiambutene US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005097
Diethyltoluamide US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005098
Diethyltryptamine US-CSA Not yet graded
CSA Schedule I
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesDET, N,N-diethyltryptamine; (Positional Isomer: N-Methyl-N-isopropyltryptamine; (MiPT))
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005099
Difamilast US-DRUG Not yet graded
US: nda
Earliest US approval2026
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005100
Difelikefalin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedKappa Opioid Receptor Agonist [EPC]; Opioid kappa Receptor Agonists [MoA]; V03AX
Earliest US approval2021
Market presence6 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005101
Difenoxin US-CSAUS-DRUG Not yet graded
CSA Schedule InarcoticUS: bulk ingredient
Class as recordedAnticholinergic [EPC]; Antidiarrheal [EPC]; Cholinergic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]
Earliest US approval1978
Market presence3 US product listings · 1 FDA applications
DEA other namesLyspafen
Etalyn identifierETA-C-005102
Diflorasone Diacetate US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
Earliest US approval1977
Market presence7 US product listings · 13 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005103
difloxacin EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQJ01MA; QJ01MA94
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005104
Diflunisal EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; N02BA11; Non-Steroidal [CS]
Earliest US approval1982
Market presence11 US product listings · 10 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005105
Difluprednate US-DRUG Not yet graded
US: anda
Earliest US approval2008
Market presence16 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005106
digestive enzyme protease, lipase, amylase, glucoamylase, invertase, cellulase, malt diastase EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Helps to encrease bioavailability of nutritient from food, supports vitality and activity of organism, break down the foods we eat into basic building blocks that our body then absorbs and reassembles to build cells, tissues, organs, glands, and body systems and to reuse for more metabolic process” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005107
Digitalinum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005108
Digitalis CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]
Market presence90 US product listings · 2 Canadian licensed products
Etalyn identifierETA-C-005109
Digitalis purpurea CA-NHP Not yet graded
CA licensed ingredient
Market presence19 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005110
Digitalis Purpurea Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005111
Digitoxin US-DRUG Not yet graded
Earliest US approval1978
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005112
Digitoxinum CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005113
Digoxin US-DRUG Not yet graded
US: anda
Class as recordedCardiac Glycoside [EPC]; Cardiac Glycosides [CS]
Earliest US approval1954
Market presence74 US product listings · 20 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005114
Dihexa US-DRUG Not yet graded
US: bulk ingredient
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005115
Dihydro-.alpha.-Ergocryptine Mesylate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005116
Dihydrocodeine US-CSAUS-DRUG Not yet graded
CSA Schedule IInarcoticUS: anda
Class as recordedCentral Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; DEA: narcotic / opioid; Full Opioid Agonists [MoA]
Earliest US approval1958
Market presence2 US product listings · 10 FDA applications
DEA other namesDidrate; Parzone
Etalyn identifierETA-C-005117
Dihydrocodeine combination product 90 mg/du Dihydrocodeine preparations 100mg/ US-CSA Not yet graded
CSA Schedule IIInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesSynalgos-DC; Compal
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005118
Dihydroergotamine US-DRUG Not yet graded
US: anda
Class as recordedErgotamine Derivative [EPC]; Ergotamines [CS]
Earliest US approval1946
Market presence25 US product listings · 19 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005119
Dihydroetorphine US-CSA Not yet graded
CSA Schedule IInarcotic
Class as recordedDEA: narcotic / opioid
DEA other namesDHE
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005120
Dihydromorphine US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005121
Dihydrostreptomycin Sulfate US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005122
Dihydroxyaluminum Sodium Carbonate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005123
Dill US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence15 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005124
Diltiazem HCL US-DRUG Not yet graded
US: anda
Class as recordedCalcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005126
Diltiazem Malate US-DRUG Not yet graded
US: anda
Class as recordedCalcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]
Earliest US approval1982
Market presence320 US product listings · 72 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005125
Dimenhydrinate US-DRUG Not yet graded
US: anda
Class as recordedHistamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
Earliest US approval1972
Market presence41 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005127
Dimenoxadol US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005128
Dimepheptanol US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005129
Dimercaprol US-DRUG Not yet graded
Earliest US approval1946
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005130
Dimethachlon US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005131
Dimethicone US-DRUG Not yet graded
US: anda
also: Dimethicone, Unspecified
Class as recordedAcidifying Activity [MoA]; Alkalinizing Activity [MoA]; Allergens [CS]; Amide Local Anesthetic [EPC]
Market presence724 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005132
Dimethicone 100 US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005133
Dimethicone 20 US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005134
Dimethicone 200 US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005135
Dimethicone 350 US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Grain Proteins [EXT]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005136
Dimethicone 410 US-DRUG Not yet graded
US: drug for further processing
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005137
Dimethicone 500 US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005138
Dimethiconol/trimethylsiloxysilicate Crosspolymer (40/60 W/w US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005139
Dimethyl Fumarate EU-MEDUS-DRUG Not yet graded
Dimethyl Phthalate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005141
Dimethyl Sulfoxide US-DRUG Not yet graded
US: anda
Earliest US approval1978
Market presence3 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005143
Dimethylglycine CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005144
Dimethylmercury CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005145
Dimethylthiambutene US-CSA Not yet graded
CSA Schedule Inarcotic
Class as recordedDEA: narcotic / opioid
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005146
Dimethyltryptamine US-CSA Not yet graded
CSA Schedule I
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesDMT
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-005147
Dimetilsolfone EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Importante sorgenti di zolfo biodisponibile, utile per una corretta sintesi della cheratina,la principale proteina costutuente le unghie. Clarification provided Source of bioavailable sulphur useful for the physiological synthesis of keratin the main constituent of nails” | Non-authorised | Art.13(1) | EFSA opinion |
| “Importante sorgenti di zolfo biodisponibile, utile per una corretta sintesi della cheratina,la principale proteina costutuente le unghie. Clarification provided Source of bioavailable sulphur useful for the physiological synthesis of keratin the main constituent of nails” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-005148
Dimocarpus longan CA-NHP Not yet graded
CA licensed ingredient
Market presence130 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005149
Dimpylate US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005151
Dimyristoyl Lecithin US-DRUG Not yet graded
Earliest US approval2002
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005152
Dinalbuphine Sebacate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005153
Dinitolmide US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005154
Dinoprost Tromethamine US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005155
Dinoprostone US-DRUG Not yet graded
US: bulk ingredient
Class as recordedProstaglandin Analog [EPC]; Prostaglandins [CS]
Earliest US approval1977
Market presence7 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005156
dinotefuran EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005157
Dinutuximab EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: bla
Class as recordedGlycolipid Disialoganglioside-directed Antibody Interactions [MoA]; Glycolipid Disialoganglioside-directed Antibody [EPC]; L01FX06
Earliest US approval2015
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-005158
Dinutuximab beta EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01FX06
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-005159
Diopside CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005160
Diornithine Oxoglurate US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAmino Acid [EPC]; Amino Acids [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005161
Dioscorea Alata Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005163
Dioscorea bulbifera CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005164
Dioscorea Cayenensis Tuber US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-005165
Dioscorea collettii var. hypoglauca CA-NHP Not yet graded
CA licensed ingredient
Market presence51 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005166
Dioscorea Composita CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005167
Dioscorea esculenta EU-NOVEL Not yet graded
Not novel in food
also: Dioscorea aculeata Roxb.
Parts in scopeRoots (tuber)
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-005168
Dioscorea futschauensis CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005169
Dioscorea hypoglauca CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005170
Dioscorea nipponica CA-NHP Not yet graded
CA licensed ingredient
Market presence15 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005171
Dioscorea opposita CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005172
Dioscorea oppositifolia CA-NHP Not yet graded
CA licensed ingredient
Market presence826 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-005173